Hanmi Pharm. Co., Ltd.
128940
Rang in Aktien
#4356
A globally active pharmaceutical company, Hanmi Pharm. Co., Ltd. was... A globally active pharmaceutical company, Hanmi Pharm. Co., Ltd. was established in Seoul, South Korea, in 1973. The firm concentrates its efforts on researching and developing medical therapies for a range of health issues, including diabetes, obesity, cancer, autoimmune disorders, and various rare diseases.
Aktienkurs
$279.16
Marktkapitalisierung
$3.54B
Veränderung (1 Tag)
-2.37%
Veränderung (1 Jahr)
14.50%
Land
KR
Handel Hanmi Pharm. Co., Ltd. (128940)
Kategorie
Healthcare
Kursverlauf für Hanmi Pharm. Co., Ltd. (128940)
Höchster Schlusskurs: $308.29 am 2026-10-01
Niedrigster Schlusskurs: $51.68 am 2010-07-01
Niedrigster Schlusskurs: $51.68 am 2010-07-01
Kursverlauf der Aktie von Hanmi Pharm. Co., Ltd. von 2010 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2026 (TTM) | 6.70% |
| 2025 | 60.36% |
| 2024 | -24.52% |
| 2023 | 17.28% |
| 2022 | -4.08% |
| 2021 | -26.35% |
| 2020 | 26.34% |
| 2019 | -35.85% |
| 2018 | -19.34% |
| 2017 | 105.14% |
| 2016 | -53.35% |
| 2015 | 617.47% |
| 2014 | -17.58% |
| 2013 | 6.45% |
| 2012 | 105.41% |
| 2011 | -22.89% |
| 2010 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $171.67 | - |
DE
|
|
| $165.31 | 23.62% |
DE
|
|
| $40.45 | 43.11% |
JP
|
|
| $224.81 | 31.28% |
CH
|
|
| $18.43 | -4.03% |
IN
|
